| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Uniqure N.V. (QURE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. QURE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 150.4K | $6.96M | - | |
| Other | 133.2K | $6.17M | -5,237 | |
| CFO | 63.9K | $2.96M | - | |
| Dir | 53.3K | $2.47M | -10,000 | |
| Dir | 40.1K | $1.86M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2020 | Kapusta Matthew C64 | CEO, CFO, Managing Director | Sell | 51,872 | $63.90 | $3,314,501.04 | -2.2% | |
| Jan 28, 2020 | Gut Robert69 | Chief Medical Officer | Sell | 7,493 | $60.18 | $450,954.21 | -11.7% | |
| Jan 15, 2020 | Kuta Alexander Edward III81 | Executive VP, Operations | Sale+OE | 4,000 | $68.97 | $275,880.00 | -8.8% | |
| Jan 7, 2020 | Soteropoulos Paula75 | Director | Sell | 3,000 | $72.18 | $216,540.00 | -35.9% | |
| Dec 18, 2019 | Kapusta Matthew C64 | CEO, CFO, Managing Director | Sale+OE | 7,540 | $70.09 | $528,510.46 | -0.7% | |
| Dec 16, 2019 | Kuta Alexander Edward III81 | Executive VP, Operations | Sale+OE | 4,000 | $74.59 | $298,356.04 | -4.6% | |
| Dec 13, 2019 | Soteropoulos Paula75 | Director | Sale+OE | 2,000 | $70.50 | $141,000.00 | -19.3% | |
| Dec 9, 2019 | Soteropoulos Paula75 | Director | Sell | 11,582 | $64.96 | $752,349.98 | -23.6% | |
| Nov 20, 2019 | Kapusta Matthew C64 | CEO, CFO, Managing Director | Sell | 8,000 | $53.74 | $429,951.00 | -0.7% | |
| Nov 15, 2019 | Kuta Alexander Edward III81 | Executive VP, Operations | Sale+OE | 4,000 | $52.08 | $208,310.00 | -4.6% |